133 related articles for article (PubMed ID: 15532372)
1. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
Duman VL
Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
4. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
Duman VL; Shkerina LI; Shilov EM
Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
[TBL] [Abstract][Full Text] [Related]
5. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
8. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.
Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Lauque D; Puéchal X; Letellier P; Delaval P; Cordier JF; Guillevin L;
Arthritis Rheum; 2008 Feb; 58(2):586-94. PubMed ID: 18240234
[TBL] [Abstract][Full Text] [Related]
10. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
Podracká L; Böör A; Sasinka M
Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation.
Miao L; Sun J; Yuan H; Jia Y; Xu Z
Nephrology (Carlton); 2006 Oct; 11(5):449-54. PubMed ID: 17014560
[TBL] [Abstract][Full Text] [Related]
12. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
13. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
17. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
19. [A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis].
Matl I; Matousovic K; Herout V; Konecný K; Kovác A; Rychlík I; Sobotová D; Roland R; Zdichyncová I; Lánská V
Cas Lek Cesk; 1997 Feb; 136(4):120-3. PubMed ID: 9221182
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
